The broad aims of this study are to delineate areas of the brain affected during active phases of schizophrenia using regional cerebral blood flow imaging during cognitive activation. It is hypothesized that patients with schizophrenia who have active thought disorganization will fail to activate the left lateral frontal lobe of the brain and perform poorly during a task that requires the subject to access long term memory of linguistic assemblies. It is expected that this experiment will delineate differences between the disorganized and paranoid schizophrenia subtypes. Ten subjects diagnosed with schizophrenia who have active thought disorganization, ten with schizophrenia without thought disorganization but with other psychotic symptoms and ten normal controls will be recruited for comparison. Subjects will undergo Magnetic Resonance Imaging and nine Positron Emission Tomography studies using bolus infusion of Oxygen-15 labeled water during three repetitions of three cognitive states: 1) a resting state with eyes closed 2) a repeat task where the subject repeats common english nouns as they are visually presented, and ] 3) a generate task where the subject responds with a verb ( or use) for the presented noun. Several performance measures of the generate task will be obtained. Data analysis will include image averaging and subtraction procedures as well as analysis of variance to assess differences between groups and resting and activated conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Research Grants (R03)
Project #
1R03MH049433-01
Application #
3430178
Study Section
Mental Health Small Grant Review Committee (MSM)
Project Start
1992-06-01
Project End
1994-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Creighton University
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68178
Weiler, M A; Fleisher, M H; McArthur-Campbell, D (2000) Insight and symptom change in schizophrenia and other disorders. Schizophr Res 45:29-36